ERBB2 and neoplasm: We next assessed the anti-tumor efficacy of mouse A1R and A3R CAR T cells in vivo by adoptive transfer to treat E0771-Her2 tumor-bearing mice utilizing a syngeneic Her2-Tg model previously characterized by our lab21,38,40.